(Q28137734)

primary sclerosing cholangitis

inferred from title

1 reference

15

E Thorsby

0 references

Anne Spurkland

1

object named as

A Spurkland

0 references

Kirsten Muri Boberg

3

object named as

K M Boberg

0 references

author name string

S Saarinen

2

0 references

S Mitchell

4

0 references

U Broome

5

0 references

L Caballeria

6

0 references

E Ciusani

7

0 references

R Chapman

8

0 references

G Ercilla

9

0 references

O Fausa

10

0 references

I Knutsen

11

0 references

A Pares

12

0 references

F Rosina

13

0 references

O Olerup

14

0 references

E Schrumpf

Primary sclerosing cholangitis. A study of forty-two cases.

16

0 references

language of work or name

English

0 references

publication date

May 1999

0 references

published in

Tissue Antigens

0 references

volume

53

0 references

page(s)

459-69

0 references

issue

5

0 references

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Association of primary sclerosing cholangitis with HLA-B8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Association of primary sclerosing cholangitis with HLA-DRw52a?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Analysis of HLA-class II DQA1, DQB1, DRB1 and DPB1 in Italian multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Nomenclature for factors of the HLA system, 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Association of HLA class II genes with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Genetic markers may predict disease behavior in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

Risk factors in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

HLA antigens in ulcerative colitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

Etiology and pathogenesis in primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

Association of primary sclerosing cholangitis with HLA-DRw52a

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

Inability to Attribute Susceptibility to Primary Sclerosing Cholangitis to Specific Amino Acid Positions of the HLA-DRw52a Allele

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

Subdural blood patch for spinal headache

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

Serological and molecular analysis of HLA in Israeli primary sclerosing cholangitis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (α1*0501, (β1*02) or the HLA-DQ (α1*03, (β1*0302) heterodimers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

HLA matching of unrelated bone marrow transplant pairs: direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

On the HLA-DQ(α1*0501, β1*0201)-associated susceptibility in celiac disease: A possible gene dosage effect ofDQB1*0201

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis (UC)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

Distinct associations of HLA class II genes with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.530502.X

7 January 2021

10.1034/J.1399-0039.1999.530502.X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2690766

2690766

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference